Marked response to single agent trastuzumab in a patient with metastatic HER-2 gene amplified rectal cancer.
Sorscher SM. Marked response to single agent trastuzumab in a patient with metastatic HER-2 gene amplified rectal cancer. Cancer Invest. 2011 Aug; 29(7):456-9.